etoricoxib (MK0663) 120 mg + Comparator: Placebo + etoricoxib (MK0663) 90 mg
Phase 3Completed 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Pain Following a Total Abdominal Hysterectomy
Conditions
Acute Pain Following a Total Abdominal Hysterectomy
Trial Timeline
Oct 1, 2008 → Jul 1, 2010
NCT ID
NCT00788710About etoricoxib (MK0663) 120 mg + Comparator: Placebo + etoricoxib (MK0663) 90 mg
etoricoxib (MK0663) 120 mg + Comparator: Placebo + etoricoxib (MK0663) 90 mg is a phase 3 stage product being developed by Organon for Acute Pain Following a Total Abdominal Hysterectomy. The current trial status is completed. This product is registered under clinical trial identifier NCT00788710. Target conditions include Acute Pain Following a Total Abdominal Hysterectomy.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00788710 | Phase 3 | Completed |
Competing Products
20 competing products in Acute Pain Following a Total Abdominal Hysterectomy